Patent details

EP1613599 Title: A PROCESS FOR THE PREPARATION OF 5-(HALOACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES

Basic Information

Publication number:
EP1613599
PCT Application Number:
PCT/EP/2004/003479
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047250352
PCT Publication Number:
WO/2004/087668
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
A PROCESS FOR THE PREPARATION OF 5-(HALOACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES
French Title of Invention:
PROCEDE DE PREPARATION DE 5-(HALOACETYL)-8-(SUBSTITUE OXY)-(1 I H /I )-QUINOLIN-2-ONES
German Title of Invention:
EIN VERFAHREN ZUR HERSTELLUNG VON 5-(HALOACETYL)-8-(SUBSTITUIERTES OXY)-(1H)-CHINOLIN-2-ONEN
SPC Number:

Dates

Filing date:
01/04/2004
Grant date:
15/12/2010
EP Publication Date:
15/12/2010
PCT Publication Date:
14/10/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
11/01/2006
EP B1 Publication Date:
15/12/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
01/04/2019
Expiration date:
01/04/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/05/2011
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Name:
Novartis Pharma GmbH
Address:
Brunner Strasse 59, 1230 Wien, Austria (AT)

Inventor

1

Name:
LOHSE Olivier
Address:
France (FR)

2

Name:
PENN Gerhard
Address:
Switzerland (CH)

3

Name:
SCHILLING Hanspeter
Address:
Switzerland (CH)

Priority

Priority Number:
459724 P
Priority Date:
02/04/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 215/26;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
27/03/2018
Last Annual Fee Paid Number:
15
Last Annual Fee Paid Amount:
213 Euro
Payer:
MARKS & CLERK LLP
Filing date Document type Number of pages